IZO Stock Overview
Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Izotropic Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.14 |
| 52 Week High | CA$0.40 |
| 52 Week Low | CA$0.10 |
| Beta | 2.03 |
| 1 Month Change | 0% |
| 3 Month Change | -15.63% |
| 1 Year Change | -53.45% |
| 3 Year Change | -88.84% |
| 5 Year Change | -65.38% |
| Change since IPO | -59.09% |
Recent News & Updates
Shareholder Returns
| IZO | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 8.0% | 0.6% | 0.7% |
| 1Y | -53.4% | -25.7% | 5.5% |
Price Volatility
| IZO volatility | |
|---|---|
| IZO Average Weekly Movement | 23.7% |
| Medical Equipment Industry Average Movement | 11.4% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Volatility Over Time: IZO's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Bob Thast | izocorp.com |
Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation Fundamentals Summary
| IZO fundamental statistics | |
|---|---|
| Market cap | CA$6.32m |
| Earnings (TTM) | -CA$2.82m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.6x
P/E RatioIs IZO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IZO income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.82m |
| Earnings | -CA$2.82m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.051 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -52.0% |
How did IZO perform over the long term?
See historical performance and comparison